Frequently Asked Questions about Pancreatic Cancer
This section consists of our version of "answers" to very general pre-selected questions.

Pancreatic Cancer Medical Literature
Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies.
Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes.
Chromogranin A and neuron-specific enolase as prognostic markers in patients with advanced pNET treated with everolimus.
Pancreatic Cancer Select Abstracts
Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy...
Intra-arterial Chemoinfusion Prior to Chemoradiotherapy...
Phase II Study of First-line FOLFIRI for Progressive Metastatic Well-differentiated Pancreatic Endocrine Carcinoma...
Pancreatic Cancer Neuroendocrine & Carcinoid Tumor
Prognostic validity of a novel american joint committee on cancer staging classification for pancreatic neuroendocrine tumors.
Chromogranin A and Neuron-Specific Enolase as Prognostic Markers in Patients with Advanced pNET Treated with Everolimus.
|
Sign up for our Free Monthly Newsletter. science board |
speak with a counselorCall 1-800-525-3777 for free counseling on our Cancer Information and Counseling Line (CICL).
8:30 to 4:30 (U.S. Mountain Time) Mon-Fri This service is for all who are affected by pancreatic cancer and is provided in collaboration with the University of Colorado Cancer Center. speak with a survivorCall 1-800-433-0464 for a free service that will place you in contact with a fellow survivor, or to volunteer to contact someone more recently diagnosed.
This peer-to-peer connection service is offered in conjunction with the Bloch Cancer Hotline. |
donateJoin us in our effort to fight pancreatic cancer. Your contribution allows for timely delivery of critical information about pancreatic cancer.
Top Donors
Or please mail your donations to: Pancreatica 312 Fountain Avenue Pacific Grove, California 93950 Pancreatica Walks and Runs
Select one of our Walks or Runs (Toll Free) 1-855-Walk-Run (1-855-925-5786) Participate@ToFightCancer.com |